PPIs are among the most widely prescribed medications in the UK. Most were initiated for short-term use. Many patients have been on them for years without review. Stopping abruptly causes rebound acid hypersecretion, which is why a structured step-down is essential.
Full page coming soonWhy stopping PPIs abruptly makes symptoms worse than before you started, and how a gradual step-down prevents it.
GORD, H. pylori, NSAID co-prescription, Barrett's oesophagus: the indications that warrant long-term use versus those that don't.
The lifestyle changes that reduce gastric acid production and how to structure the environment for step-down success.
Using H2 antagonists as a step-down bridge between PPI and no medication.
Magnesium deficiency, vitamin B12 absorption, bone density, and kidney function: the evidence for long-term risks of continuing versus stopping.
Non-pharmacological and alternative approaches to reflux management during and after step-down.
In the meantime, if you have questions before this page is complete, contact the practice directly, or book a consultation online. Every enquiry is reviewed personally by Dr Dan Reardon.